Literature DB >> 22552441

Multiple forms of selenoprotein P in a candidate human plasma standard reference material.

Guillaume Ballihaut1, Lisa E Kilpatrick, Eric L Kilpatrick, W Clay Davis.   

Abstract

Selenoprotein P (SePP) is a unique selenium-containing protein responsible for the transport and distribution of the essential trace element selenium (Se) through the human body with the concentration of SePP in human blood representing the most useful marker of Se nutritional status. Although SePP has been extensively studied, the structure of SePP in human plasma remains unresolved. Two potential isoforms of SePP have been identified by Western blot analyses distinguished principally by differences in migration (51 kDa and 61 kDa). The biological relevance of the smaller isoform has been called into question by several studies reporting only one major SePP form (69 kDa) suggesting that the shorter 51 kDa is an artifact of protease activity during the SePP purification process. A deficiency of these Western blot analyses is that no information can be gleaned regarding the Se content of the potential isoforms. This study reports a characterization of SePP isoforms in a human plasma Standard Reference Material representative of a healthy US population. Following immunoprecipitation, three SePP isoforms were unequivocally identified at 45 kDa, 49 kDa and 57 kDa (termed as SePP45, SePP49 and SePP57) by LC-MS/MS analyses from a spectral searching approach. Selenium (Se) was detected by gel electrophoresis LA-ICP-MS in SePP49 and SePP57 which was confirmed by the identification of three selenopeptides covering the SePP sequence from residues 312-346 by LC-MS/MS analyses utilizing a sequence searching approach. Conversely, neither Se nor peptides covering SePP sequence from residues 306-346 was identified in SePP45 which suggests that SePP45 is a truncated isoform transcriptionally terminated at the 2nd in-frame UGA codon thereby terminating the protein with the Ser residue at position 299. An additional band at 23 kDa was found to contain Se but no peptides of SePP. Instead, glutathione peroxidase 3 (GPx3) was unequivocally identified within the band presumably being co-immunoprecipitated with the SePP providing preliminary evidence that SePP and GPx3 interaction may take place in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552441     DOI: 10.1039/c2mt20059g

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  6 in total

Review 1.  Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease.

Authors:  Sarah P Short; Jennifer M Pilat; Christopher S Williams
Journal:  Free Radic Biol Med       Date:  2018-05-17       Impact factor: 7.376

2.  Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite.

Authors:  Marco Vinceti; Nikolay Solovyev; Jessica Mandrioli; Catherine M Crespi; Francesca Bonvicini; Elisa Arcolin; Eleni Georgoulopoulou; Bernhard Michalke
Journal:  Neurotoxicology       Date:  2013-05-31       Impact factor: 4.294

3.  Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics.

Authors:  Jacklyn N Hellwege; Nicholette D Palmer; Julie T Ziegler; Carl D Langefeld; Carlos Lorenzo; Jill M Norris; Toshinari Takamura; Donald W Bowden
Journal:  Gene       Date:  2013-10-24       Impact factor: 3.688

4.  Sex-specific and inter-individual differences in biomarkers of selenium status identified by a calibrated ELISA for selenoprotein P.

Authors:  Sandra Hybsier; Torsten Schulz; Zida Wu; Ilja Demuth; Waldemar B Minich; Kostja Renko; Eddy Rijntjes; Josef Köhrle; Christian J Strasburger; Elisabeth Steinhagen-Thiessen; Lutz Schomburg
Journal:  Redox Biol       Date:  2016-12-29       Impact factor: 11.799

Review 5.  Characterization and Quantification of Selenoprotein P: Challenges to Mass Spectrometry.

Authors:  Jérémy Lamarche; Luisa Ronga; Joanna Szpunar; Ryszard Lobinski
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

6.  Selenoprotein P as Biomarker of Selenium Status in Clinical Trials with Therapeutic Dosages of Selenite.

Authors:  Ola Brodin; Julian Hackler; Sougat Misra; Sebastian Wendt; Qian Sun; Elena Laaf; Christian Stoppe; Mikael Björnstedt; Lutz Schomburg
Journal:  Nutrients       Date:  2020-04-12       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.